Nanodrug-based modulation of platelet–leukocyte interactions in ovarian cancer: a new frontier in targeted therapy

Nanodrug-based modulation of platelet–leukocyte interactions in ovarian cancer: a new frontier in targeted therapy

Abstract Ovarian cancer (OC) remains a leading cause of gynecologic cancer mortality due to its biological heterogeneity, late-stage diagnosis, and resistance to conventional therapies. The tumor microenvironment (TME) plays a critical role in driving disease progression, with pathological interacti...

Full description

Saved in:
Bibliographic Details
Main Authors: Jalal Naghinezhad, Somayeh Moradpanah, Nastaran Khodakarim, Michael R. Hamblin, Hadi Rezaeeyan
Format: Article
Language:English
Published: BMC 2025-08-01
Series:Cancer Nanotechnology
Subjects:
Ovarian cancer
Tumor microenvironment
Nanoparticle
Platelet leukocyte aggregates
Transforming growth factor-β1
Neutrophil extracellular trap
Online Access:https://doi.org/10.1186/s12645-025-00340-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12645-025-00340-3

Similar Items